A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia

AMPA-receptor-positive modulators (Ampakines) facilitate learning and memory in animal models and in preliminary trials in human subjects. CX516 is the first Ampakine to be studied for cognitive enhancement in schizophrenia. Stable schizophrenia patients treated with clozapine (n=52), olanzapine (n=...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Goff, Donald C, Lamberti, Steven, Leon, Andrew C, Green, Michael F, Miller, Alexander L, Patel, Jayendra, Manschreck, Theo, Freudenreich, Oliver, Johnson, Steven A
Format: Artigo
Jezik:Inglês
Izdano: 2007
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098468/
https://ncbi.nlm.nih.gov/pubmed/17487227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.npp.1301444
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki